Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis

Thrombosis and Haemostasis

Volumn 96, Issue 6, 2006, Pages 830-838

  Jesmin, Subrina ^a   Gando, Satoshi ^a   Zaedi, Sohel ^a   Sakuraya, Fumika ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coagulation; Endotoxin; Inflammation; Liver injury; Protease activated receptor (PAR)

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 7A; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; ISOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; RECEPTOR BLOCKING AGENT; SC 9278P; THROMBIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT; BLOOD CLOTTING; CENTRAL VEIN; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FIBRIN DEPOSITION; FIBRINOLYSIS; HEPATIC ARTERY; IMMUNOREACTIVITY; KUPFFER CELL; LIVER CELL; LIVER INJURY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR BLOCKING; SEPSIS;

ACUTE DISEASE; ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; DISEASE MODELS, ANIMAL; FIBRIN; FIBRINOLYSIS; HUMANS; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES; PEPTIDES; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RECEPTORS, PROTEINASE-ACTIVATED; RECEPTORS, THROMBIN; RNA, MESSENGER; SEPSIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845358121     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-07-0379     Document Type: Article

References (29)

1. Dhainaut JF, Marin N, Mignon A, et al. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001, 29 (Suppl): S42-S7.
2. Pastor CM, Billiar TR, Losser MR, et al. Liver injury during sepsis. J Crit Care 1995; 10: 183-97.
3. Su GL. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 2002; 283: G256-G65.
4. Luster MI, Germolec DR, Yoshida T, et al. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 1994; 19: 480-8.
5. Hewett JA, Jean PA, Kunkel SL, et al. Relationship between tumor necrosis factor-α and neutrophils in endotoxin-induced liver injury. Am J Physiol Gastrointest Liver Physiol 1993; 265: G1011-G5.
6. Doi F, Goya T, Torisu M. Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis. Hepatology 1993; 17: 1086-94.
7. Shibayama Y. Sinusoidal circulatory disturbance by microthrombosis as a cause of endotoxin-induced hepatic injury. J Pathol 1987; 151: 315-21.
8. Todoroki H, Nakamura S, Higure A, et al. Neutrophils express tissue factor in a monkey model of sepsis. Surgery 2000; 127: 209-16.
9. Mochida S, Arai M, Ohno A, et al. Deranged blood coagulation equilibrium as factor of massive liver necrosis following endotoxin administration in partially bepatectomized rats. Hepatology 1999; 29: 1532-40.
10. Quax PA, van den Hoogen CM, Verheijen JH, et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissue in vivo. J Biol Chem 1990; 26: 15560-3.
11. Fearns C, Loskutoff DJ. Induction of plasminogen activator inhibitor 1 gene expression in marine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor-α. Am J Pathol 1997; 150: 579-90.
12. Yamashita M, Yamashita M. Tumor necrosis factor alpha is involved in the induction of plasminogen activator inhibitor-1 by endotoxin. Thromb Res 1997; 87: 165-70.
13. Esmon CT. Inflammation and thrombosis. J Thromb Haemost 2003; 1: 1343-8.
14. Coughlin SR. Thrombin signaling and protease-activated receptors. Nature 2000; 407: 258-64.
15. Dugina TN, Kiseleva EV, Chistov IV, et al. Receptors of the PARs family as a link between blood coagulation and inflammation. Biochemistry (Moscow) 2002; 67: 65-74.
16. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. PNAS 2000; 97; 5255-60.
17. Riewald M, Ruf W. Orchestration of coagulation protease signaling by tissue factor. Trend Cardiovascular Med 2002; 12: 149-54.
18. Copple BL, Moulin F, Hanumegowda UM, et al. Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers. J Pharmacol Exp Ther 2003; 305; 417-25.
19. Nystedt S, Ramakrishnan V, Sundelin J. The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. J Biol Chem 1996; 271: 14910-5.
20. Hamilton JR, Frauman AG, Cocks TM. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res 2001; 89: 92-8.
21. Jesmin S, Gando S, Matsuda N, et al. Temporal changes in pulmonary expression of key coagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thromb Haemost 2004; 92: 966-79.
22. Jesmin S, Sakuma I, Salah-Eldin A, et al. Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction in diabetes. J Mol Endocrinol 2003; 31: 401-18.
23. Maeda S, Miyauchi T, Iemitsu M, et al. Effects of exercise training on expression of endothelin-1 mRNA in the aorta of aged rats. Clin Sci (Lond) 2002; Suppl 48: 118S-23S.
24. Levi M, de Jonge E, van der Poll T. Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis 2003; 16: 43-7.
25. Pearson JM, Schultze AE, Schwartz KA, et al. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat. J Pharmacol Exp Ther 1996; 278: 378-83.
26. Vergnolle N. Proteinase-activated receptor-2 activating peptides induce leucocyte rolling, adhesion, and extravasation in vivo. J Immunol 1999; 163: 5064-9.
27. Blackhart BD, Emilsson K, Nguyen D, et al. Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 1996; 271: 16466-71.
28. Pawlinski R, Pedersen B, Schabbauer G, et al. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood 2004; 103: 1342-7.
29. Katakaoka H, Hamilton JR, McKemy DD, et al. Protease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cells. Blood 2003; 102: 3224-31.